Trial Profile
Phase 2 study of AXL1717 in patients with non-small cell lung cancer in India.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 05 May 2017
Price :
$35
*
At a glance
- Drugs Picropodophyllin (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 20 Aug 2015 New trial record